Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of antidepressants and antipsychotic drugs. Its structure supports the creation of bioactive molecules that modulate neurotransmitter activity in the central nervous system. Commonly employed in research settings for designing novel piperazine-based compounds with potential neurological and psychiatric applications. Also utilized in the preparation of selective serotonin reuptake inhibitors (SSRIs) due to its ability to enhance drug stability and receptor binding affinity.